IRIS UniCatt

Macchia, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.469
NA - Nord America 7.300
AS - Asia 5.714
SA - Sud America 1.162
AF - Africa 186
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 13
Totale 21.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.070
DE - Germania 2.914
SG - Singapore 2.838
CN - Cina 1.499
SE - Svezia 1.363
BR - Brasile 985
IT - Italia 652
UA - Ucraina 561
FR - Francia 423
GB - Regno Unito 342
IN - India 324
IE - Irlanda 319
VN - Vietnam 238
FI - Finlandia 237
ID - Indonesia 200
PL - Polonia 185
CA - Canada 141
TR - Turchia 130
RU - Federazione Russa 124
HK - Hong Kong 74
BD - Bangladesh 70
AR - Argentina 64
JP - Giappone 64
NL - Olanda 58
CI - Costa d'Avorio 54
BE - Belgio 53
IQ - Iraq 49
MX - Messico 46
AT - Austria 42
CZ - Repubblica Ceca 42
ZA - Sudafrica 39
ES - Italia 31
IR - Iran 30
KR - Corea 27
LT - Lituania 27
CO - Colombia 24
EC - Ecuador 23
MA - Marocco 22
SA - Arabia Saudita 21
EG - Egitto 20
AE - Emirati Arabi Uniti 18
UZ - Uzbekistan 18
KE - Kenya 17
VE - Venezuela 17
PK - Pakistan 15
JM - Giamaica 14
CL - Cile 13
EU - Europa 11
PH - Filippine 11
PY - Paraguay 11
UY - Uruguay 11
CH - Svizzera 10
JO - Giordania 10
RO - Romania 10
IL - Israele 9
AL - Albania 8
AU - Australia 8
BH - Bahrain 8
NP - Nepal 8
PE - Perù 8
RS - Serbia 8
BG - Bulgaria 7
GR - Grecia 7
HU - Ungheria 7
PT - Portogallo 7
TN - Tunisia 7
AM - Armenia 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
ET - Etiopia 6
BO - Bolivia 5
CR - Costa Rica 5
KZ - Kazakistan 5
LK - Sri Lanka 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
SN - Senegal 5
DK - Danimarca 4
KG - Kirghizistan 4
MT - Malta 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
HN - Honduras 3
HR - Croazia 3
LB - Libano 3
NO - Norvegia 3
PA - Panama 3
AO - Angola 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
Totale 21.829
Salva come PNG Salva come JPEG
Città #
Chandler 1.363
Singapore 1.348
Ashburn 690
Beijing 344
Jacksonville 321
Dublin 316
San Mateo 260
Nanjing 199
New York 198
Los Angeles 194
Jakarta 191
Wilmington 181
Dearborn 165
Warsaw 164
Munich 159
The Dalles 153
Milan 142
Boston 140
Nürnberg 140
Hefei 132
Bremen 123
Dallas 116
Woodbridge 115
Marseille 112
Ann Arbor 106
Hyderabad 105
Frankfurt am Main 104
Rome 99
São Paulo 97
Helsinki 88
Houston 88
Izmir 88
Lawrence 85
Cattolica 84
Princeton 79
Ho Chi Minh City 77
Moscow 77
Fairfield 76
Nanchang 76
Hanoi 70
Hong Kong 62
Seattle 62
Redwood City 56
Abidjan 54
Brussels 53
Buffalo 49
Toronto 46
Leawood 40
Santa Clara 39
Chicago 38
Zhengzhou 37
Düsseldorf 36
London 36
University Park 36
Tokyo 35
Turku 35
Kent 34
Shenyang 34
Hebei 32
Kunming 32
Phoenixville 32
Stockholm 32
Augusta 30
Montreal 30
Tianjin 30
Fremont 29
Guangzhou 29
Lancaster 29
Boardman 28
Brooklyn 28
Changsha 27
Nuremberg 27
Cambridge 26
Jiaxing 26
Falls Church 25
Mountain View 25
Seoul 25
Shanghai 25
Rio de Janeiro 24
Norwalk 23
Pune 23
Atlanta 22
Detroit 22
Johannesburg 22
North York 22
Phoenix 22
Vienna 22
Amsterdam 21
Auburn Hills 20
San Francisco 20
Brno 19
Denver 19
Hangzhou 19
Mumbai 18
Redmond 18
Belo Horizonte 17
Bexley 17
Lauterbourg 17
Baghdad 16
Brasília 16
Totale 10.453
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 834
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 286
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 207
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 203
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 192
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 191
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 185
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 181
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 179
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 178
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 176
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 174
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 170
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 169
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 169
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 169
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 168
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 168
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 167
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 165
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 165
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 163
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 163
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 163
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 163
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 159
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 159
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 157
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 156
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 155
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 154
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 153
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 153
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 152
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 151
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 150
In Vivo Portal Dosimetry by an Ionization Chamber 148
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 148
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 147
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 147
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 147
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 147
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 146
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 145
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 144
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 143
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 142
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 141
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 139
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 139
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 138
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 136
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 135
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 134
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 134
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 133
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 133
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 129
Real time transit dosimetry for the breath-hold radiotherapy technique experience 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 129
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 129
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 128
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 127
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 126
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 125
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 124
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 124
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 119
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 119
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 119
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 119
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 118
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 118
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 116
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 116
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 116
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 116
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 114
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 114
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 112
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 110
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 110
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 109
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 109
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 108
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 108
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 108
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 107
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 107
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 107
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 107
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 105
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 105
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 104
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 104
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups 103
Totale 14.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021688 0 0 0 0 0 48 128 31 129 98 197 57
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.772 106 84 240 136 419 103 97 175 600 446 729 637
2025/20265.058 1.417 296 552 962 1.702 129 0 0 0 0 0 0
Totale 22.561